Renalytix plc (RENXF) Free cash flow 2019–2024
Renalytix plc (RENXF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$30.1MFY2024 · since FY2019: -$6.5M → -$30.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$30.1M | +11.6% |
| FY2023 | -$34.1M | +26.7% |
| FY2022 | -$46.5M | -59.3% |
| FY2021 | -$29.2M | -182.5% |
| FY2020 | -$10.3M | -59.7% |
| FY2019 | -$6.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RENXF financial trends
RENXF RevenueRENXF Net incomeRENXF Net marginRENXF Gross profitRENXF Gross marginRENXF Operating incomeRENXF Operating marginRENXF Operating cash flowRENXF Capital expendituresRENXF Return on equityRENXF Stock buybacksRENXF Dividends paidRENXF Total assetsRENXF Total liabilitiesRENXF Shareholders’ equityRENXF overview →